359 results on '"Sant, Andrea J"'
Search Results
2. CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines
3. A previously unappreciated polymorphism in the beta chain of I-As expressed in autoimmunity-prone SJL mice: Combined impact on antibody, CD4 T cell recognition and MHC class II dimer structural stability
4. Flublok Quadrivalent Vaccine Adjuvanted with R-DOTAP Elicits a Robust and Multifunctional CD4 T Cell Response That Is of Greater Magnitude and Functional Diversity Than Conventional Adjuvant Systems
5. Learning from our differences
6. copepodTCR: Identification of Antigen-Specific T Cell Receptors with combinatorial peptide pooling
7. Overarching Immunodominance Patterns and Substantial Diversity in Specificity and Functionality in the Circulating Human Influenza A and B Virus–Specific CD4⁺ T-Cell Repertoire
8. The use of nanolipoprotein particles to enhance the immunostimulatory properties of innate immune agonists against lethal influenza challenge
9. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
10. Heterologous viral protein interactions within licensed seasonal influenza virus vaccines
11. Nanoparticles decorated with viral antigens are more immunogenic at low surface density
12. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans
13. Energetic Asymmetry among Hydrogen Bonds in MHC Class II·Peptide Complexes
14. Overview of T-Cell Recognition
15. List of Contributors
16. R-DOTAP Cationic Lipid Nanoparticles Outperform Squalene-Based Adjuvant Systems in Elicitation of CD4 T Cells after Recombinant Influenza Hemagglutinin Vaccination
17. Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection
18. Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report
19. Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza
20. Effect of Influenza A(H5N1) Vaccine Prepandemic Priming on CD4⁺ T-Cell Responses
21. Editorial overview: The life and times of peptide-MHC
22. CD4⁺ T-Cell Expansion Predicts Neutralizing Antibody Responses to Monovalent, Inactivated 2009 Pandemic Influenza A(H1N1) Virus Subtype H1N1 Vaccine
23. The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History.
24. The Negative Effect of Preexisting Immunity on Influenza Vaccine Responses Transcends the Impact of Vaccine Formulation Type and Vaccination History
25. Development of a Mouse Model to Explore CD4 T Cell Specificity, Phenotype, and Recruitment to the Lung after Influenza B Infection
26. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
27. Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
28. Abortive Activation of CD4 T Cell Responses during Competitive Priming in vivo
29. Selection of immunodominant CD4 T cell epitopes in responses to peptide vaccination
30. Abundance and specificity of influenza reactive circulating memory follicular helper and non-follicular helper CD4 T cells in healthy adults
31. Predominant Role of Amino-Terminal Sequences in Dictating Efficiency of Class II Major Histocompatibility Complex α β Dimer Expression
32. Identification of a Sulfate-Bearing Molecule Associated with HLA Class II Antigens
33. Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge
34. Referee report. For: Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses [version 1; peer review: 1 approved, 1 approved with reservations]
35. The relative energetic contributions of dominant P1 pocket versus hydrogen bonding interactions to peptide:class II stability: Implications for the mechanism of DM function
36. Understanding the focused CD4 T cell response to antigen and pathogenic organisms
37. 6 - Descripción general del reconocimiento de los linfocitos T: hacer que los microbios patógenos sean visibles para el sistema inmunitario
38. Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age
39. Peptide-binding motifs for the I-[A.sup.d] MHC class II molecule: Alternate pH-dependent binding behavior
40. Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host
41. The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity
42. 6 - Overview of T-Cell Recognition: Making Pathogens Visible to the Immune System
43. Human influenza reactivity to conserved influenza hemagglutinin and its relation to age and repeat vaccination
44. Potentiating lung-localized immune responses to conserved influenza virus antigen through a novel vaccine platform
45. Peptide Epitope Hot Spots of CD4 T Cell Recognition Within Influenza Hemagglutinin During the Primary Response to Infection
46. Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study
47. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A (super)d protein using two functionally distinct registers
48. Conformation of MHC class II I-Ag7 is sensitive to the P9 anchor amino acid in bound peptide
49. Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design
50. Endogenous antigen presentation by MHC class II molecules
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.